Skip to Content

UK publishes new 5 year AMR action plan with focus on diagnostic stewardship

On January 24th the United Kingdom published its latest action plan to tackle antimicrobial resistance: Tackling antimicrobial resistance 2019–2024: The UK’s five-year national action plan, alongside a 20-year vision on how to tackle the crisis.

UK publishes new 5 year AMR action plan with focus on diagnostic stewardship

The plan contains a number of targets including:

  • Halve healthcare associated Gram-negative blood stream infections;
  • Reduce the number of specific drug-resistant infections in people by 10% by 2025;
  • Reduce UK antimicrobial use in humans by 15% by 2024;
  • Reduce UK antibiotic use in food-producing animals by 25% between 2016 and 2020 and define new objectives by 2021 for 2025;
  • Be able to report on the percentage of prescriptions supported by a diagnostic test or decision support tool by 2024.

One of the main focus areas of the strategy is to support the rapid uptake of diagnostics.

To support rapid uptake of diagnostics, the UK will:

  • Make antimicrobials and diagnostics a priority area for the Accelerated Access Pathway.
  • Use modelling and test-pilot data to develop alternative funding models for faster diagnostics that support targeted treatment. This includes commissioning work to develop a method for assessing the value of new technologies that considers not only cost effectiveness but the value proposition at a system level.
  • Maximise use of NICE guidance, including the Medical Technology Innovation briefs, to assess new diagnostic tests and offer prescribers advice on their use.
  • Streamline the regulation process to help get new diagnostics through as quickly as possible, including developing evidence-based guidance for using tests.

The full report can be found here: https://www.gov.uk/government/publications/uk-5-year-action-plan-for-antimicrobial-resistance-2019-to-2024

The companies, websites, products and services, and brands referenced and linked to/from this website are not sponsored or endorsed by, or otherwise affiliated with, Abbott or TestTargetTreat.com. The third-party products and services referenced and linked to/ from this website are included for informational purposes only, and have not been tested or approved by Abbott or TestTargetTreat.com. Neither Abbott nor TestTargetTreat.com makes any representations or warranties regarding third-party products or services, and shall not be liable for any claims arising from those products or services or your use thereof.

Explore Related Content and Videos

News

AMR Industry Alliance Produces First Report

News

Free Online Course on Antimicrobial Stewardship – Register Now!

Read more here

G20 Health Ministers commit to reducing the inappropriate use of antibiotics through the use of diagnostics

G20 Health Ministers commit to reducing the inappropriate use of antibiotics through the use of diagnostics

Read more here